 | Up a level |
2019
Bazarbachi, Ali, Boumendil, Ariane, Finel, Herve, Mohty, Mohamad, Castagna, Luca, Blaise, Didier, Peggs, Karl S., Afanasyev, Boris, Diez-Martin, J. L., Corradini, Paolo, Michonneau, David 
ORCID: 0000-0003-4553-3065, Robinson, Stephen, Gutierrez Garcia, Gonzalo, Bonifazi, Francesca, Yakoub-Agha, Ibrahim, Gulbas, Zafer, Bloor, Adrian, Delage, Jeremy, Esquirol, Albert, Malladi, Ram, Scheid, Christof, El-Cheikh, Jean, Ghesquieres, Herve, Montoto, Silvia, Dreger, Peter and Sureda, Anna
(2019).
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer, 125 (1).
S. 90 - 99.
HOBOKEN:
WILEY.
ISSN 1097-0142
2017
Martinez, Carmen, Gayoso, Jorge, Canals, Carmen, Finel, Herve, Peggs, Karl, Dominietto, Alida, Castagna, Luca, Afanasyev, Boris, Robinson, Stephen, Blaise, Didier, Corradini, Paolo, Itala-Remes, Maija, Bermudez, Arancha, Forcade, Edouard, Russo, Domenico, Potter, Michael, McQuaker, Grant, Yakoub-Agha, Ibrahim ORCID: 0000-0003-4524-8782, Scheid, Christof, Bloor, Adrian, Montoto, Silvia ORCID: 0000-0002-3006-9725, Dreger, Peter and Sureda, Anna
(2017).
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
J. Clin. Oncol., 35 (30).
S. 3425 - 3436.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2010
Wendtner, Clemens, Hillmen, Peter, Mahadevan, Daruka, Stilgenbauer, Stephan, Uharek, Lutz, Coutre, Steven, Frankfurt, Olga, Bloor, Adrian, Bosch, Francesc ORCID: 0000-0001-9241-2886, Furman, Richard R., Kimby, Eva, Gribben, John G., Gobbi, Marco, Dreisbach, Luke, Hurd, David Duane, Sekeres, Mikkael A., Ferrajoli, Alessandra, Shah, Sheetal, Zhang, Jennie, de Parseval, Laure Moutouh and Chanan-Khan, Asher A.
(2010).
Final Results of the Phase I Study of Lenalidomide In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL-001 Study).
Blood, 116 (21).
S. 591 - 593.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 0006-4971